-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
SEATTLE, March 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ:DNDN) will release its fourth quarter financial results on Thursday, March 13, 2008. Company management will host a conference call at 8:00 a.m. PT; 11:00 a.m. ET to review fiscal year 2007 financial results and provide 2008 financial guidance. Access to the discussion may be obtained as follows:
Time: 11:00 AM ET /8:00 AM PT
About Dendreon Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/. First Call Analyst:
CONTACT: investor relations, Jennifer Williams of Dendreon Corporation, Web site: http://www.dendreon.com/
2008-03-06 19:05:10 0306927 PRNEWSWIRE
HOME || Press Release Archive || © Leigh Media Corporation || Terms of Use || Privacy Policy || Publish Your Press Release Here |